Neurogene Inc.
NGNE
$15.22
-$0.29-1.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.65M | -19.51M | -20.22M | -18.49M | -16.92M |
| Total Depreciation and Amortization | 762.00K | 798.00K | 807.00K | 817.00K | 825.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.53M | 2.12M | 1.28M | 2.66M | 1.20M |
| Change in Net Operating Assets | -1.41M | -896.00K | 2.56M | -879.00K | -6.75M |
| Cash from Operations | -20.77M | -17.50M | -15.56M | -15.89M | -21.65M |
| Capital Expenditure | -780.00K | -116.00K | -167.00K | -460.00K | -65.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -44.27M | -102.50M | -28.80M | -23.15M | 30.00M |
| Cash from Investing | -45.05M | -102.62M | -28.97M | -23.61M | 29.94M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -15.00K | -13.00K | -12.00K | -16.00K | -11.00K |
| Issuance of Common Stock | 19.00K | 190.08M | 143.00K | 415.00K | 629.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 0.00 | -7.14M |
| Cash from Financing | 4.00K | 190.07M | 131.00K | 399.00K | -6.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -65.82M | 69.95M | -44.40M | -39.11M | 1.76M |